Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Pulmonary Artery Embolization in the Management of Hemoptysis Related to Lung Tumors

Amandine CLAUDINOT
* ORCID logo ,
Frédéric Douane
,
Olivier Morla
,
Christophe Perret
,
Marine Neveu
,
Francine Thouveny
* ORCID logo ,
Antoine Bouvier
,
Jose Hureaux
,
Arnaud Le Guen
ORCID logo ,
Jeremy Jouan
,
Jean Francois Heautot
,
Antoine Larralde
* ,
Damiano Cerasuolo
,
Emmanuel Bergot
,
Audrey Fohlen
,
Jean Pierre Pelage
Version 1 : Received: 22 October 2023 / Approved: 23 October 2023 / Online: 23 October 2023 (08:39:09 CEST)

A peer-reviewed article of this Preprint also exists.

Claudinot, A.; Douane, F.; Morla, O.; Perret, C.; Neveu, M.; Thouveny, F.; Bouvier, A.; Hureaux, J.; Le Guen, A.; Jouan, J.; Heautot, J.-F.; Larralde, A.; Cerasuolo, D.; Bergot, E.; Fohlen, A.; Pelage, J.-P. Pulmonary Artery Embolization in the Management of Hemoptysis Related to Lung Tumors. J. Pers. Med. 2023, 13, 1597. Claudinot, A.; Douane, F.; Morla, O.; Perret, C.; Neveu, M.; Thouveny, F.; Bouvier, A.; Hureaux, J.; Le Guen, A.; Jouan, J.; Heautot, J.-F.; Larralde, A.; Cerasuolo, D.; Bergot, E.; Fohlen, A.; Pelage, J.-P. Pulmonary Artery Embolization in the Management of Hemoptysis Related to Lung Tumors. J. Pers. Med. 2023, 13, 1597.

Abstract

(1) Background: Bronchial artery embolization has been shown to be effective in the management of neoplastic hemoptysis. However, knowledge of pulmonary artery embolization is lacking. To evaluate safety and efficacy of pulmonary artery embolization in patients presenting with hemoptysis related to lung tumors. (2) Methods: This retrospective study reviewed all consecutive patients with cancer and at least one episode of hemoptysis that required pulmonary artery embolization from December 2008 to December 2020. The endpoints of the study were technical success, clinical success, recurrence of hemoptysis and complications. (3) Results: A total of 92 patients were treated with pulmonary artery embolization (63.1 years ± 9.9; 70 men). Most patients had stage III or IV advanced disease. Pulmonary artery embolization was technically successful in 82 (89%) patients and clinically successful in 77 (84%) patients. Recurrence occurred in 49% of patients. Infectious complications occurred in 15 patients (16%). The 30-days mortality rate was 31%. At 3 years, survival rate was 3.6%. Tumor size, tumor cavitation and necrosis and pulmonary artery pseudo-aneurysm were significantly associated with recurrence and higher mortality. (4) Conclusions: Pulmonary artery embolization is an effective treatment to initially control hemoptysis in patient with lung carcinoma but recurrence rate remains high and overall survival remains poor.

Keywords

hemoptysis; pulmonary artery; embolization; lung cancer

Subject

Public Health and Healthcare, Other

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.